Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Gastrointestinal 1

Conditions

Multiple Myeloma 9Disease 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Ovarian Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Fluorouracil 12Cisplatin 12Leucovorin 9Paclitaxel 8Radiotherapy 6Oxaliplatin 5Capecitabine 5Irinotecan 4Gastrectomy 3Epirubicin 3Trastuzumab 2Taxes 2Surgical Procedures, Operative 2Platinum 2Neoadjuvant Therapy 2Docetaxel 2uridine triacetate 1sargramostim 1pertuzumab 1carfilzomib 1Watchful Waiting 1Vorinostat 1Sorafenib 1Ramucirumab 1Radiosurgery 1Preoperative Exercise 1Polymerase Chain Reaction 1Ondansetron 1Lithium 1Lapatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Stomach Neoplasms × carfilzomib × Clear all
NCT01941316 2024-05-09

Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients

Cancer Research and Biostatistics Clinical Trials Consortium

Phase 1/2 Completed
78 enrolled 15 charts
GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡